240 related articles for article (PubMed ID: 33122123)
1. Current medical management of hereditary angioedema: Follow-up survey of US physicians.
Riedl MA; Banerji A; Gower R
Ann Allergy Asthma Immunol; 2021 Mar; 126(3):264-272. PubMed ID: 33122123
[TBL] [Abstract][Full Text] [Related]
2. Current medical management of hereditary angioedema: follow-up survey of US physicians.
Riedl MA; Banerji A; Gower R
J Allergy Clin Immunol Pract; 2015; 3(2):220-7. PubMed ID: 25609328
[TBL] [Abstract][Full Text] [Related]
3. Canadian physician survey on the medical management of hereditary angioedema.
Fu L; Kanani A; Lacuesta G; Waserman S; Betschel S
Ann Allergy Asthma Immunol; 2018 Nov; 121(5):598-603. PubMed ID: 29958877
[TBL] [Abstract][Full Text] [Related]
4. Interventions for the long-term prevention of hereditary angioedema attacks.
Beard N; Frese M; Smertina E; Mere P; Katelaris C; Mills K
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013403. PubMed ID: 36326435
[TBL] [Abstract][Full Text] [Related]
5. Hereditary Angioedema With Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns.
Riedl MA; Danese M; Danese S; Ulloa J; Maetzel A; Audhya PK
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2450-2456.e6. PubMed ID: 36720386
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
[TBL] [Abstract][Full Text] [Related]
7. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
[TBL] [Abstract][Full Text] [Related]
8. Current medical management of hereditary angioedema: results from a large survey of US physicians.
Riedl M; Gower RG; Chrvala CA
Ann Allergy Asthma Immunol; 2011 Apr; 106(4):316-322.e4. PubMed ID: 21457880
[TBL] [Abstract][Full Text] [Related]
9. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?
Lunn ML; Santos CB; Craig TJ
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):211-4. PubMed ID: 20377110
[TBL] [Abstract][Full Text] [Related]
10. Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs.
Riedl MA; Craig TJ; Banerji A; Aggarwal K; Best JM; Rosselli J; Hahn R; Radojicic C
Allergy Asthma Proc; 2021 May; 42(3):S17-S25. PubMed ID: 33980329
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Sabharwal G; Craig T
Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
[TBL] [Abstract][Full Text] [Related]
12. Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs.
Bouillet L; Fain O; Armengol G; Aubineau M; Blanchard-Delaunay C; Dalmas MC; De Moreuil C; Du Thanh A; Gobert D; Guez S; Hoarau C; Jaussaud R; Jeandel PY; Maillard H; Marmion N; Masseau A; Menetrey C; Ollivier Y; Pelletier F; Plu-Bureau G; Sailler L; Vincent D; Bouquillon B; Verdier E; Clerson P; Boccon-Gibod I; Launay D
Allergy Asthma Proc; 2022 Sep; 43(5):406-412. PubMed ID: 35868842
[No Abstract] [Full Text] [Related]
13. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
Riedl M
Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
[TBL] [Abstract][Full Text] [Related]
14. Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate.
Riedl MA; Hinds DR; Prince PM; Alvord TM; Dosenovic S; Abdelhadi JF; Brownrigg JR; Camp CL; Machnig T; Banerji A
Allergy Asthma Proc; 2023 Jul; 44(4):275-282. PubMed ID: 37328263
[No Abstract] [Full Text] [Related]
15. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M
Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784
[TBL] [Abstract][Full Text] [Related]
16. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
[TBL] [Abstract][Full Text] [Related]
17. A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom.
Yong PFK; Coulter T; El-Shanawany T; Garcez T; Hackett S; Jain R; Kiani-Alikhan S; Manson A; Noorani S; Stroud C; Symons C; Sargur R; Steele C; Alachkar H; Anantharachagan A; Arkwright PD; Bernatoniene J; Bhole M; Brown L; Buckland M; Burns S; Chopra C; Darroch J; Drewe E; Edmonds J; Ekbote A; Elkhalifa S; Goddard S; Grosse-Kreul D; Gurugama P; Hague R; Herriot R; Herwadkar A; Hughes SM; Jones L; Lear S; McDermott E; Kham Murng SH; Price A; Redenbaugh V; Richter A; Riordan A; Shackley F; Stichbury J; Springett D; Tarzi MD; Thomas M; Vijayadurai P; Worth A
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2476-2483. PubMed ID: 37146882
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States.
Riedl MA; Banerji A; Manning ME; Burrell E; Joshi N; Patel D; Machnig T; Tai MH; Watson DJ
Orphanet J Rare Dis; 2018 Oct; 13(1):180. PubMed ID: 30314518
[TBL] [Abstract][Full Text] [Related]
19. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
Riedl M
Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
[TBL] [Abstract][Full Text] [Related]
20. Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist Analyses.
Mendivil J; Malmenäs M; Haeussler K; Hunger M; Jain G; Devercelli G
Drugs R D; 2021 Mar; 21(1):113-121. PubMed ID: 33646565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
